Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikuma Hamada

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Oncology|April 25, 2009
The role of meta-analysis in cancer clinical trialsChikuma Hamada
Nihon Geka Gakkai Zasshi|August 19, 2015
[STATISTICAL VIEWPOINTS ON DESIGNING INVESTIGATOR INITIATED CLINICAL TRIALS]Chikuma Hamada
Journal of Toxicologic Pathology|February 27, 2018
Statistical analysis for toxicity studiesChikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 12, 2009
[Statistics used in pharmacological research]Chikuma Hamada
Pharmaceutical Statistics|August 17, 2018
A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinationsShinjo Yada, Chikuma Hamada
Therapeutic Innovation & Regulatory Science|September 19, 2018
Adaptive Seamless Design for Establishing Pharmacokinetic and Efficacy Equivalence in Developing BiosimilarsRyuji Uozumi, Chikuma Hamada
Pharmaceutical Statistics|November 29, 2016
Application of Bayesian hierarchical models for phase I/II clinical trials in oncologyShinjo Yada, Chikuma Hamada
Contemporary Clinical Trials Communications|April 27, 2018
Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trialsShinjo Yada, Chikuma Hamada
Journal of Biopharmaceutical Statistics|February 17, 2016
Interim decision-making strategies in adaptive designs for population selection using time-to-event endpointsRyuji Uozumi, Chikuma Hamada
Pharmaceutical Statistics|August 26, 2017
Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycleShinjo Yada, Chikuma Hamada
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Oncology|April 25, 2009
The role of meta-analysis in cancer clinical trialsChikuma Hamada
Nihon Geka Gakkai Zasshi|August 19, 2015
[STATISTICAL VIEWPOINTS ON DESIGNING INVESTIGATOR INITIATED CLINICAL TRIALS]Chikuma Hamada
Journal of Toxicologic Pathology|February 27, 2018
Statistical analysis for toxicity studiesChikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 12, 2009
[Statistics used in pharmacological research]Chikuma Hamada
Pharmaceutical Statistics|August 17, 2018
A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinationsShinjo Yada, Chikuma Hamada
Therapeutic Innovation & Regulatory Science|September 19, 2018
Adaptive Seamless Design for Establishing Pharmacokinetic and Efficacy Equivalence in Developing BiosimilarsRyuji Uozumi, Chikuma Hamada
Pharmaceutical Statistics|November 29, 2016
Application of Bayesian hierarchical models for phase I/II clinical trials in oncologyShinjo Yada, Chikuma Hamada
Contemporary Clinical Trials Communications|April 27, 2018
Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trialsShinjo Yada, Chikuma Hamada
Journal of Biopharmaceutical Statistics|February 17, 2016
Interim decision-making strategies in adaptive designs for population selection using time-to-event endpointsRyuji Uozumi, Chikuma Hamada
Pharmaceutical Statistics|August 26, 2017
Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycleShinjo Yada, Chikuma Hamada
Pageof 10